Dash Bio (Series A)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
July 23, 2025
Vertical
Bioanalysis
Funding Amount
$11,000,000
Company Info
Market
Drug Development
Location
Boston, MA, USA
Coinvestors
The Aligned Fund, Freestyle Capital, Cybernetix Ventures, Swift Ventures, LifeX Ventures, Drive Capital
Company Description

Dash Bio is a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development.

Links